Aro Biotherapeutics



Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.


Add photos to showcase Aro Biotherapeutics’s culture


Add Aro Biotherapeutics’s values

Insider experiences

Share your experience of working at Aro Biotherapeutics

Susan Dillon
Co-Founder, President & CEO
Mittie Doyle
Chief Medical Officer
Karyn O’Neil
Co-Founder & Chief Scientific Officer
Mark Laurenzi
Chief Administrative Officer & VP, Legal
Sukumar Sakamuri
Chief Technology Officer
Jeffrey Staiger
SVP, Finance & Business Development
Steven Nadler
SVP, Discovery & Translational Research
Adam Dinerman
Head, Chemistry, Manufacturing & Controls & Executive Director

Add your teams to show how people work together at Aro Biotherapeutics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.